Aveanna Healthcare Q3 2026 results beat estimates and raise full‑year guidance
Aveanna Healthcare reported third‑quarter 2026 revenue of $695.5 million, up 11.8% year‑over‑year, and non‑GAAP earnings per share of $0.23, beating consensus. Adjusted EBITDA rose 25% to $100.1 million. The company lifted its full‑year 2026 revenue outlook to more than $2.695 billion and adjusted EBITDA outlook to more than $374 million, citing strong segment growth and state rate enhancements, including a $30 million California funding commitment that could total $60 million.
Why it matters
The raised guidance signals higher future cash flow and earnings potential, which may affect valuation models and target prices (e.g., Raymond James’s $15.00 price target). The $60 million California rate investment could improve margins in the Private Duty Services segment.
Key facts
- 1Q3 2026 revenue was $695.5 million, up 11.8% YoY. seekingalpha.com
- 2Non‑GAAP EPS for the quarter was $0.23, beating estimates by $0.02. seekingalpha.com
- 3Adjusted EBITDA increased 25% to $100.1 million. rttnews.com
- 4Full‑year 2026 revenue guidance was raised to greater than $2.695 billion. rttnews.com
- 5Full‑year 2026 Adjusted EBITDA guidance was raised to greater than $374 million. rttnews.com
- 6California budget includes $30 million in state funding for PDN rates, with a matching $30 million federal contribution for a total $60 million investment. finance.yahoo.com
Summary written by AlphAI AI Desk from 12 of 12 sources. Not investment advice. Figures are as stated by the linked sources.